JV

Jaydipkumar Vinodchandra Parmar

Active Director Director DIN 10226353
DIN 10226353 First appointment Jul 2023 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Jaydipkumar Vinodchandra Parmar

Data last updated:

Jaydipkumar Vinodchandra Parmar is a Director at Davakart Pharmacy Private Limited (since 2023). The company operates in Pharma.

DIN 10226353
Primary Designation Director
Industry Pharma
First Appointment 05 Jul 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Davakart Pharmacy Private Limited U46497GJ2023PTC142639
Director05 Jul 20232023Active

Board colleagues of Jaydipkumar Vinodchandra Parmar

Directorship timeline

Open interactive timeline →
Davakart Pharmacy Private Limited
Premium access

Shareholding and investment profile for Jaydipkumar Vinodchandra Parmar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Jaydipkumar Vinodchandra Parmar

Jaydipkumar Vinodchandra Parmar currently holds 1 directorship: Davakart Pharmacy Private Limited (Director, since 05 Jul 2023).

Jaydipkumar Vinodchandra Parmar was first appointed on 05 Jul 2023 as Director at Davakart Pharmacy Private Limited.

The current boards of Jaydipkumar Vinodchandra Parmar's companies include Jayeshkumar Chorasiya (Davakart Pharmacy Private Limited), Meetkumar Vinodkumar Parmar (Davakart Pharmacy Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available